Director of SEC Reporting & Technical Accounting, HeartFlow
$170-230k
Plus cash bonus and stock options
Medical equipment manufacturing
Job no longer available
Medical equipment manufacturing
501-1000 employees
Job no longer available
$170-230k
Plus cash bonus and stock options
501-1000 employees
Company mission
To establish a new era of personalized care by delivering AI-driven analysis and insights to proactively manage CAD for life.
Role
Who you are
- CPA required
- 7-10 years’ experience including 5+ years of public accounting
- 2+ of experience in financial reporting and SEC reporting
- S-1 & IPO Experience a plus
- Extensive filing of 10k and 10Q for multiple entities a must
- Thorough understanding of GAAP and SEC regulations
- Strong analytical and technical accounting skills
- Excellent communication and interpersonal skills
- Extremely Detail-oriented
- Ability to work effectively in a fast-paced, deadline-driven environment
- Proficiency in financial software and reporting tools
- Knowledge of Sarbanes-Oxley Act (SOX) compliance
What the job involves
- The Director of Technical Accounting and External Reporting is responsible for all technical accounting and SEC reporting matters, manage the documentation, review and communication of conclusions on the appropriate accounting for complex transactions and contracts and adoptions of new accounting standards
- The Director will assist with key business and strategic activities, initiatives and transactions while advising on the appropriate accounting treatment
- The Director will oversee the preparation and filing of accurate and timely financial reports and disclosures required by the SEC
- This role plays a critical part in ensuring the organization complies with regulatory standards and provides transparent financial information to shareholders and investors
- SEC Filings: MUST - Prepare and manage the submission of periodic SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and other required filings, ensuring compliance with all regulatory requirements
- Financial Statements: Coordinate the preparation of financial statements, footnotes, and other disclosures for SEC filings, ensuring they adhere to Generally Accepted Accounting Principles (GAAP) and SEC regulations
- Technical Accounting: Stay current with changes in accounting standards and SEC regulations, writing memos and providing guidance on their impact on financial reporting and disclosures
- Financial Analysis: Analyze financial data to ensure accuracy and completeness, identify potential issues, and recommend improvements in financial reporting processes
- Internal Controls: Establish and maintain effective internal controls related to SEC reporting to ensure the integrity and accuracy of financial information
- Coordination: Collaborate with cross-functional teams, including finance, legal, and external auditors, to gather necessary information and support for SEC filings
- Disclosure Committee: Participate in or lead the disclosure committee meetings to review and approve financial disclosures and ensure consistency and accuracy
- SOX Compliance: Mange and assist with the assessment, testing and documentation of internal controls related to financial reporting (SOX compliance)
- Stock Based comp: Assist with the accounting for stock based compensation arrangements and financial reporting
- Filing Deadlines: Manage the SEC reporting calendar to ensure all filing deadlines are met and communicate any potential delays or issues
Our take
HeartFlow is a medical equipment manufacturer that uses CT-scanned 3D modelling to assess and analyze a patient's heart and arteries. This non-invasive process can help assess the risks of Coronary Artery Disease (CAD) and strategize the appropriate treatment.
As the world’s leading cause of death, CAD is a worthy target for improved diagnosis and treatment. HeartFlow's approach enables clinicians to deliver more effective treatments faster, making CAD more manageable than ever before.
The company has a long history of awards and innovations, adopting technological advancements as they happen. It successfully launched its IPO in 2021, although a 2022 merger with Longview Acquisitions was called off due to unfavourable market conditions. Despite this, the company remains steadfast, unveiling new technology that ensures better treatment for CAD patients.
Steph
Company Specialist at Welcome to the Jungle
Insights
4% employee growth in 12 months
Company
Funding (last 2 of 11 rounds)
Mar 2025
$98m
CONVERTIBLE
Apr 2023
$215m
SERIES F
Total funding: $980.6m
Company benefits
- Medical / Dental / Vision (90% of premium paid by Heartflow)
- Flexible Spending and Health Savings Accounts
- 401k plan with employer match
- Company holidays
- Paid sick time and vacation
- Parental leave
- EAP Program
- Free snacks and drinks
- Fitness competition, Blood drive, Waffle Wednesdays and more!
Company HQ
Old Mountain View, Mountain View, CA
Leadership
John Farquhar
(President & CEO)Joined HeartFlow in 2021 as the President and Chief Operating Officer and became the CEO in 2022. Prior to this, they were the VP and General Manager at Medtronic. They also spent 5 years as a Professional Football Player in the NFL.
Share this job
View 12 more jobs at HeartFlow